HedgeChatter

  • Home /
  • Tag Archives

SYN

Synthetic Biologics to Report First Quarter 2014 Financial Results

[PR Newswire] – ROCKVILLE, Md., May 9, 2014 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections … moreView todays social media effects on SYNView the latest stocks trending across Twitter. Click to view dashboardSee who Synthetic is hiring next, click here to view […]

May 9, 2014 Bystocknews , Comments Off on Synthetic Biologics to Report First Quarter 2014 Financial Results read more

7:29 am Synthetic Biologics granted new patents in Europe and receives notice of allowance in Australia that provide composition of matter coverage for various aspects of its C. difficile program

moreView todays social media effects on SYNView the latest stocks trending across Twitter. Click to view dashboardSee who Synthetic is hiring next, click here to view […]

May 8, 2014 Bystocknews , Comments Off on 7:29 am Synthetic Biologics granted new patents in Europe and receives notice of allowance in Australia that provide composition of matter coverage for various aspects of its C. difficile program read more

Synthetic Biologics Announces Recent International Patents that Bolster its C. difficile Program

[PR Newswire] – ROCKVILLE, Md., May 8, 2014 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced tod moreView todays social media effects on SYNView the latest stocks trending across Twitter. Click to view dashboardSee who Synthetic is hiring next, click here […]

May 8, 2014 Bystocknews , Comments Off on Synthetic Biologics Announces Recent International Patents that Bolster its C. difficile Program read more

SYNTHETIC BIOLOGICS, INC. Financials

moreView todays social media effects on SYNView the latest stocks trending across Twitter. Click to view dashboardSee who Synthetic is hiring next, click here to view […]

April 5, 2014 Bystocknews , Comments Off on SYNTHETIC BIOLOGICS, INC. Financials read more

7:12 am Synthetic Biologics announces issuance of U.S. patent adding another layer of protection for the use of oral estriol candidate, Trimesta, for multiple sclerosis

moreView todays social media effects on SYNView the latest stocks trending across Twitter. Click to view dashboardSee who Synthetic is hiring next, click here to view […]

March 11, 2014 Bystocknews , Comments Off on 7:12 am Synthetic Biologics announces issuance of U.S. patent adding another layer of protection for the use of oral estriol candidate, Trimesta, for multiple sclerosis read more

Synthetic Biologics’ Board of Directors Accepts Resignation of Long-Standing Founder and Board Member

[PR Newswire] – ROCKVILLE, Md., Feb. 26, 2014 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases, announced t moreView todays social media effects on SYNView the latest stocks trending across Twitter. Click to view dashboardSee who Synthetic is hiring next, click here […]

February 26, 2014 Bystocknews , Comments Off on Synthetic Biologics’ Board of Directors Accepts Resignation of Long-Standing Founder and Board Member read more